Insights & Resources

Massachusetts warns that a medical environment does not expand an aesthetician’s scope, even with a physician on-site or overseeing care.

New York LLCs, including med spa MSOs, must disclose beneficial owners by 2027 and update filings within 30 days of ownership changes.

California is tightening telehealth standards for GLP-1s, IV therapy, and injectables, with stronger expectations for live video and patient-specific orders.

Colorado now requires signage, website disclosures, and informed consent when unlicensed staff perform delegated medical-aesthetic services.

Colorado HB 26-1249 could let PAs and APRNs hold majority ownership in med spas, while current disclosure and oversight requirements still apply.

Indiana now requires med spas to report serious adverse events within five days, making emergency protocols and fast internal escalation essential.

Florida SB 1728 could require some med spas handling Botox, GLP-1s, or other prescription drugs to obtain a Board of Pharmacy license.

Massachusetts H 5087 would tier med spas by risk, with Level II and III requiring clinical or medical directors and added licensing obligations.

Offering GLP-1 medications in a wellness clinic setting requires a precise legal structure. Learn how to offer GLP-1 services legally and safely.